BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 17447184)

  • 1. Obsessive-compulsive disorders due to neuroacanthocytosis treated with citalopram.
    Habermeyer B; Fuhr P
    Pharmacopsychiatry; 2007 Mar; 40(2):87. PubMed ID: 17447184
    [No Abstract]   [Full Text] [Related]  

  • 2. Obsessive-compulsive disorder due to neuroacanthocytosis treated with citalopram. A case report.
    Habermeyer B; Fuhr P; Hiss B; Alber C; Müller-Spahn F
    Pharmacopsychiatry; 2006 Sep; 39(5):193-4. PubMed ID: 16944412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obsessive-compulsive disorders due to neuroacanthocytosis treated with citalopram.
    Walker RH; Danek A
    Pharmacopsychiatry; 2007 May; 40(3):132; author reply 132-3. PubMed ID: 17541893
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of the selective serotonin reuptake inhibitor citalopram in a possible animal analogue of obsessive-compulsive disorder.
    Stein DJ; Mendelsohn I; Potocnik F; Van Kradenberg J; Wessels C
    Depress Anxiety; 1998; 8(1):39-42. PubMed ID: 9750979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of childhood obsessive-compulsive disorder with citalopram.
    Maud C; Stein DJ
    S Afr Med J; 1996 Jun; 86(6 Suppl):746, 748. PubMed ID: 9180769
    [No Abstract]   [Full Text] [Related]  

  • 6. Response of symptom dimensions in obsessive-compulsive disorder to treatment with citalopram or placebo.
    Stein DJ; Andersen EW; Overo KF
    Braz J Psychiatry; 2007 Dec; 29(4):303-7. PubMed ID: 18200396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endophenotypes and serotonergic polymorphisms associated with treatment response in obsessive-compulsive disorder.
    Corregiari FM; Bernik M; Cordeiro Q; Vallada H
    Clinics (Sao Paulo); 2012; 67(4):335-40. PubMed ID: 22522758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond depression: citalopram for obsessive-compulsive disorder.
    Pato MT
    Int Clin Psychopharmacol; 1999 May; 14 Suppl 2():S19-26. PubMed ID: 10471169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Citalopram in refractory obsessive-compulsive disorder: an open study.
    Marazziti D; Dell'Osso L; Gemignani A; Ciapparelli A; Presta S; Nasso ED; Pfanner C; Cassano GB
    Int Clin Psychopharmacol; 2001 Jul; 16(4):215-9. PubMed ID: 11459335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Citalopram for OCD and Tourette's syndrome.
    Wehr AM; Namerow LB
    J Am Acad Child Adolesc Psychiatry; 2001 Jul; 40(7):740-1. PubMed ID: 11437010
    [No Abstract]   [Full Text] [Related]  

  • 11. Citalopram in the treatment of obsessive-compulsive disorder: an open pilot study.
    Koponen H; Lepola U; Leinonen E; Jokinen R; Penttinen J; Turtonen J
    Acta Psychiatr Scand; 1997 Nov; 96(5):343-6. PubMed ID: 9395151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New pharmacotherapeutic approaches to obsessive-compulsive disorder.
    Figee M; Denys D
    CNS Spectr; 2009 Feb; 14(2 Suppl 3):13-23. PubMed ID: 19238126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbamazepine for serotonin reuptake inhibitor nonresponder case of obsessive compulsive disorder.
    Aggarwal A; Jain M; Garg A; Jiloha RC
    Indian J Med Sci; 2009 Oct; 63(10):468-9. PubMed ID: 19901487
    [No Abstract]   [Full Text] [Related]  

  • 14. Citalopram intravenous infusion in resistant obsessive-compulsive disorder: an open trial.
    Pallanti S; Quercioli L; Koran LM
    J Clin Psychiatry; 2002 Sep; 63(9):796-801. PubMed ID: 12363120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized controlled clinical trial of citalopram versus fluoxetine in children and adolescents with obsessive-compulsive disorder (OCD).
    Alaghband-Rad J; Hakimshooshtary M
    Eur Child Adolesc Psychiatry; 2009 Mar; 18(3):131-5. PubMed ID: 19190958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose escitalopram treatment in patients with obsessive-compulsive disorder: a naturalistic case series.
    Shim GS; Kang DH; Kwon JS
    J Clin Psychopharmacol; 2008 Feb; 28(1):108-10. PubMed ID: 18204356
    [No Abstract]   [Full Text] [Related]  

  • 17. Escitalopram in the treatment of obsessive-compulsive disorder.
    Zohar J
    Expert Rev Neurother; 2008 Mar; 8(3):339-49. PubMed ID: 18345966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obsessive-compulsive disorder: an open-label pilot trial of escitalopram.
    Galvão-de Almeida A; Quarantini LC; Góis CR; Santos-Jesus R; Miranda-Scippa AM; de Oliveira IR; da Silva Prado H; Leckman JF; Rosário MC
    CNS Spectr; 2007 Jul; 12(7):519-24. PubMed ID: 17603402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Citalopram for treatment-resistant obsessive-compulsive disorder.
    Pallanti S; Quercioli L; Paiva RS; Koran LM
    Eur Psychiatry; 1999 Apr; 14(2):101-6. PubMed ID: 10572334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical efficacy of citalopram in patients with obsessive-compulsive disorder].
    Jakitowicz J; Nowicki Z; Wiśniewski G
    Psychiatr Pol; 2002; 36(6 Suppl):297-301. PubMed ID: 12647452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.